胺与电治疗治疗耐药抑郁症:随机临床试验的二次分析
Manish Kumar Jha1,2, Samuel T Wilkinson3, Kamini Krishnan4
1Center for Depression Research and Clinical Care, Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas.
JAMA network open
|June 25, 2024
概括
与电震治疗 (ECT) 相比,静脉胺在治疗耐药抑郁症 (TRD) 的门诊患者中显示出更大的改善. 这些发现表明胺可能是某些TRD患者的首选选择.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 临床试验 临床试验
背景情况:
- 耐治疗抑郁症 (TRD) 影响了大部分患有重度抑郁症的患者.
- 电疗法 (ECT) 和胺是TRD的既定治疗方法,但指导选择的临床特征的直接比较数据有限.
- 此前,ELEKT-D试验已经确定了相对于非精神病性TRD,相比于ECT,氨酸的非劣势性.
研究的目的:
- 调查是否特定的基线临床特征预测TRD患者的静脉胺和ECT之间的治疗反应差异.
- 通过确定可能从一种治疗中获益更多的患者子组,为共享决策提供信息.
主要方法:
- 开放标签,非劣势ELEKT-D随机临床试验的二次分析.
- 多中心研究涉及365名患有非精神病性TRD的患者,随机分为3周接受胺注射或ECT治疗.
- 重复测量混合效应模型评估了基线因素 (例如,QIDS-SR16,MADRS,认知功能,患者状态) 与抑郁症症状减少之间的关联.
主要成果:
- 门诊患者中度严重的抑郁症 (QIDS-SR16 ≤ 20) 显示,基胺治疗比ECT治疗更有改善.
- 患有非常严重抑郁症 (QIDS-SR16 > 20) 的住院患者最初通过ECT显示出更大的改善,治疗结束时的得分相似.
- 在ECT组中,更高的先发性智力和并发性PTSD与更大的MADRS得分降低有关.
结论:
- 静脉胺可能是一个比ECT更有效的选择,非精神病TRD的门诊患者经历中度至重度抑郁症.
- 临床特征,如抑郁症的严重程度和患者的状态 (住院/门诊),可以帮助指导选择胺和ECT之间的TRD.
- 进一步的研究可以根据个体患者的特征来完善TRD的个性化治疗选择.
相关概念视频
Electroconvulsive Therapy
31
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
31
Psychosis: Goals of Pharmacotherapy
122
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
122
Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
Antiepileptic Drugs: Potassium Channel Activators
169
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
169
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
Psychosurgery
53
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
53


